- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT01084317
Evaluation of the Delay in Asthma Diagnosis in Children From the Lodz Region
Evaluation of the Delay in Asthma Diagnosis in Children From the Lodz Region After the Program for Prevention of Allergic Diseases
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The object of this study is asthma, the most common chronic childhood disease. The disease has become epidemic in developed countries and also in Poland. The percentage of children suffering from bronchial asthma in Lodz is one of the highest in the country (8.5%. Bronchial asthma in children of Lodz is a real challenge not only for doctors but also for public health professionals. This study is to assess the long-term effects of innovation on a national scale Prevention Program of Allergic Diseases, which was carried out in 2000-2003 in the region of Lodz. This Program has given many positive effects, most of all, improvement in the diagnosis of allergic diseases, availability of medical specialists and reduction the number of hospitalizations because of the disease exacerbation.
The aim of the research is to assess the duration of a delay in asthma diagnosis in children after the Program for Prevention of Allergic Diseases. Risk factors for delayed diagnosis of asthma in children will also be assessed. This study will answer the question of whether this ratio depends on the time, which indirectly proves that it can be changed by local intervention programs. Prove lasting effects of the Program may contribute to planning further local interventions focused on improving medical care for patients with bronchial asthma in the Lodz region, and reduce social costs associated with this disease.
Subject of study are patients under 18 age, with newly diagnosed asthma, who were under care in Allergy Clinic in Copernicus Hospital in Lodz in 2004-2009. Selected clinic is the largest pediatric allergy center in the region and was also the largest center participating in the Program for Prevention of Allergic Diseases and the only center, which analyzed the delay in asthma diagnosis among patients. Children's medical documentation will be analyzed as far as following data were concerned: demographic data, anthropometric parameters, information about family history of atopic diseases, asthma symptoms (cough, dyspnoea, wheezing, reducing physical activity, and recurrent respiratory infections) and symptoms of other atopic diseases in both the current and in the past. In addition, information will be collected on the child's family situation, housing conditions and the presence of animals in the house. Data obtained from the children's medical documentation will be supplemented by telephone interview conducted with parents of the child. The group of patients with underdiagnosed asthma will be classified as children who experienced frequent wheezing (at least 4 episodes per year) and 1 major criterium (positive family history of allergic diseases or symptoms of atopic as infants) or two smaller criteria (symptoms of food allergies, the increased number of eosinophilic cells in the peripheral blood or wheezing without infection). For each child the time from appearance of asthma symptoms (according to the API - asthma predictive index) to diagnose the disease by a specialist will be set. This time will be defined as duration of undiagnosed asthma. Due to the fact that the delay in asthma diagnosis is dependent on the patient's age, the analysis will be carried out in four groups separated on the basis of the upper and lower quartiles of respondents age.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Lodz, Polen, 93-513
- Department of Social and Preventive Medicine, Medical University of Lodz, Poland, Department of Pediatrics and Allergy, N. Copernicus Hospital, Medical University of Lodz, Poland
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- patients under 18 age, with newly diagnosed asthma
Exclusion Criteria:
- patients under 18 age, without newly diagnosed asthma
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Tilbagevirkende kraft
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
|---|---|
|
asthmatic children
patients under 18 age, with newly diagnosed asthma
|
medical documentation analysis supplemented by telephone interview conducted with parents of the child
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
duration of a delay in asthma diagnosis in children
Tidsramme: 5 years
|
The duration of a delay in asthma diagnosis in children after the Program for Prevention of Allergic Diseases
|
5 years
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Studiestol: Włodzimierz Stelmach, MD, PhD, Department of Social and Preventive Medicine, Medical University of Lodz, Poland
- Studieleder: Iwona Stelmach, MD,PhD,Prof., Department of Pediatrics and Allergy, N. Copernicus Hospital, Medical University of Lodz, Poland
- Ledende efterforsker: Ewa Bąk, Master of Sc, Department of Social and Preventive Medicine, Medical University of Lodz, Poland
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- RNN/603/09/KB
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Bronkial astma
-
Centre Hospitalier Intercommunal CreteilRekrutteringBronchial dilatationssygdom | BronchectasieFrankrig
-
The Second Affiliated Hospital of Fujian Medical...Shanghai iCELL Biotechnology Co., Ltd, Shanghai, ChinaUkendt
-
Federal State Budgetary Institution, Pulmonology...Moscow State University of Medicine and Dentistry; National Medical Research... og andre samarbejdspartnereUkendtSundhed, Subjektiv | Hyperreaktivitet, BronchialDen Russiske Føderation
-
Burzynski Research InstituteAfsluttetBronchial Alveolar; SvulstForenede Stater
-
South Valley UniversityAfsluttetBronchial neoplasma benign
-
Ruijin HospitalShanghai Tong Ren Hospital; Shanghai Pulmonary Hospital, Shanghai, China; Ruijin Hospital Luwan BranchUkendtLuftvejssygdom | Fistel Bronchial | Fistel, MaveKina
-
KK Women's and Children's HospitalSingapore University of Technology and DesignUkendtHoste | URTI | Hostevariant astma | Hoste; Bronchial, med Grippe eller influenzaSingapore
-
University of Colorado, DenverBristol-Myers SquibbAktiv, ikke rekrutterendeTobaksrygning | Bronchial dysplasi | Historie om ikke-småcellet lungekræft | Historie om hoved- og halskræftForenede Stater
-
National Cancer Institute (NCI)Trukket tilbageKronisk obstruktiv lungesygdom | Lungekarcinom | Stadie II lungekræft AJCC v8 | Stadie I lungekræft AJCC v8 | Tobaksrelateret karcinom | Bronchial epitel dysplasiForenede Stater
-
US Endoscopy Group Inc.AfsluttetBarrett Esophagus | Esophageal Neoplasma | Esophageal stenose | Esophageal dysplasi | Bronchial neoplasma | Stenose af bronchus eller luftrørForenede Stater
Kliniske forsøg med medical documentation and telephone interview
-
Nemours Children's ClinicAfsluttetSeglcelleegenskabForenede Stater
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); The Leukemia and Lymphoma SocietyAfsluttetKronisk lymfatisk leukæmi | PlasmacellemyelomForenede Stater
-
Children's Oncology GroupNational Cancer Institute (NCI)AfsluttetHæmatopoietisk og lymfoid celle-neoplasma | Ondartet fast neoplasma | Akut lymfatisk leukæmi | B-celle non-Hodgkin lymfom | Tilbagevendende akut lymfatisk leukæmi i barndommen | Akut myeloid leukæmi i barndommen | Burkitt lymfom i barndommen | Neoplasma i barndommenForenede Stater, Puerto Rico
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)AfsluttetInvasivt brystkarcinomForenede Stater
-
University of North Carolina, Chapel HillViiV HealthcareAfsluttet
-
HaEmek Medical Center, IsraelUkendt
-
EDAP TMS S.A.UkendtProstatakræftForenede Stater, Canada
-
Vanderbilt UniversityAfsluttet
-
Apos Medical and Sports Technology Ltd.Afsluttet
-
University Hospital, Basel, SwitzerlandNovartis; ProPatient foundation of the University Hospital BaselAfsluttetAplastisk anæmi | Paroksysmal natlig hæmoglobinuriSchweiz